Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes mellitus and serum vitamin B12 concentrations: 333 patients.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·1957
Same author

Ammonium penicillin G: comparisons with other oral penicillin preparations.

Antibiotic medicine & clinical therapy (New York, NY)·1957
Same author

Sulfisoxazole (gantrisin): concentration in plasma and diffusion into the cerebrospinal fluid.

Journal of the American Geriatrics Society·1957
Same author

Comparison of sulfapyrimidines: a triple sulfonamide mixture, sulfisoxazole, and sulfadimetine.

Antibiotic medicine & clinical therapy (New York, NY)·1956
Same author

Novobiocin: a study of plasma and spinal fluid concentrations in man.

Antibiotic medicine & clinical therapy (New York, NY)·1956
Same author

The penicillinate of benzhydrylamine; its oral administration.

Antibiotic medicine & clinical therapy (New York, NY)·1955
Same journal

The therapeutic use of procaine in minor surgical conditions.

The Nova Scotia medical bulletin·2010
Same journal

Outbreak of typhoid fever in Trenton, Nova Scotia.

The Nova Scotia medical bulletin·2010
Same journal

Eye lessons in general practice.

The Nova Scotia medical bulletin·2010
Same journal

The neurological examination.

The Nova Scotia medical bulletin·2010
Same journal

Gonorrheal cervicitis and trichomonas vaginalis.

The Nova Scotia medical bulletin·2010
Same journal

Krukenberg tumour.

The Nova Scotia medical bulletin·2010
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Portal cirrhosis

S C STRICKLAND

    The Nova Scotia Medical Bulletin
    |March 19, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    LIVER/cirrhosis

    More Related Videos

    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
    09:37

    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

    Published on: August 1, 2018

    Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
    04:00

    Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

    Published on: November 15, 2024

    Related Experiment Videos

    Last Updated: Jun 14, 2026

    New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
    08:45

    New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

    Published on: June 27, 2025

    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
    09:37

    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

    Published on: August 1, 2018

    Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
    04:00

    Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

    Published on: November 15, 2024